Clinical trials

  • CAR20(NAP)-T for Diffuse large B-cell lymphoma | Mantle cell lymphoma | Indolent B-cell lymphoma
  • DORNASE ALFA for Acute respiratory distress syndrome | Severe trauma
  • ETOPOSIDE for Hemophagocytic lymphohistiocytosis (HLH)
  • Diltiazem hydrochloride for Angina | Coronary microvascular dysfunction
  • ETOPOSIDE for Hemophagocytic lymphohistiocytosis
  • Nadofaragene firadenovec for Non-muscle invasive bladder cancer (intermediate risk)
  • Esmolol hydrochloride for Cardiogenic shock
  • Protamine sulfate for Severe aortic stenosis
  • POLYINOSINIC:POLYCYTIDYLIC ACID for Basal cell carcinoma
  • Dostarlimab for Endometrial cancer (MMRd/MSI-H, stage II–III)
  • SOTORASIB for Non-small cell lung cancer | Colorectal cancer | Advanced solid tumour (KRAS p.G12C mutant)
  • Genetically modified T-cells (ROR1-targeted) for Adrenocortical carcinoma | Breast cancer | Chronic lymphocytic leukemia | Ovarian cancer | Mantle cell lymphoma